文献速递外周动脉疾病

慢性肢体威胁性缺血患者的条件生存分析及死亡危险因素

Conditional survival analysis and risk factors for mortality in patients with chronic limb-threatening ischemia.
PubMed 文献 · J Vasc Surg · 2025-05-09

该回顾性队列纳入2007至2017年3865例慢性肢体威胁性缺血(CLTI)患者,5年总生存率为29.5%;存活至诊断后2年者再存活1年至第3年的概率为83%,存活至3年者存活至第4年的概率为82%;多因素分析显示溃疡、血液透析、诊断时入住ICU、缺血性心脏病、养老机构居住和卒中史与死亡增加相关,氯吡格雷使用和门诊诊断与死亡降低相关。

要点

  • CLTI患者5年总生存率为29.5%,但存活超过第一年后条件生存改善。
  • 存活至2年者再存活1年的概率为83%,存活至3年者再存活1年的概率为82%。
  • 多因素分析中溃疡、血液透析、诊断时入住ICU、缺血性心脏病、养老机构居住和卒中史与死亡增加相关。

核心结论

  • CLTI患者存活超过诊断后第一年时条件生存改善,但5年死亡率仍高。
  • 存活第一年显著改善后续生存几率,但CLTI早期死亡风险仍然很大。
  • 许多导致早期死亡风险的因素是可改变的,凸显了针对该高危人群进行针对性干预的重要性。

研究设计与样本

  • 回顾性收集本机构数据库2007至2017年经国际疾病分类第9版和第10版代码识别的CLTI患者数据。
  • 从诊断时开始进行Kaplan-Meier生存分析,采用单因素和多因素Cox回归模型识别与死亡相关的因素。

主要发现

  • 共纳入3865例CLTI患者,5年总生存率为29.5%。
  • 存活至诊断后2年的患者再存活1年(至第3年)的概率为83%,存活至3年的患者存活至第4年的概率为82%。
  • 多因素分析中与死亡增加显著相关的因素包括伴溃疡的CLTI、需要血液透析、诊断时入住ICU、缺血性心脏病、养老机构居住和卒中史。
  • 多因素分析中与死亡降低相关的因素包括氯吡格雷使用和门诊诊断。
  • 阿司匹林使用在单因素分析中与死亡降低相关,但在多因素分析中不显著。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVE: Overall survival (OS) for patients with chronic limb-threatening ischemia (CLTI) is notably poor, yet traditional survival estimates made at diagnosis fail to account for changes in survival probability over time. Conditional survival (CS) provides a dynamic measure of survival, indicating the likelihood that a patient will survive an additional period, given that they have already lived a certain number of years. Our study aimed to apply this model, commonly used in oncology, to evaluate how clinical presentation, comorbidities, and management impact continued survival in patients with CLTI. Specifically, we sought to determine: (1) conditional survival at 1, 3, and 5 years for patients with CLTI; and (2) the risk factors associated with survival outcomes. METHODS: Data were retrospectively collected from our institutional database, identifying patients with CLTI through International Classification of Diseases-9 and -10 codes between 2007 and 2017. Kaplan-Meier survival analysis was conducted from the time of diagnosis. Baseline characteristics from medical records were assessed for their impact on OS. Univariate and multivariate Cox regression models were used to identify factors associated with mortality. RESULTS: A total of 3865 patients with a CLTI diagnosis were included. The 5-year overall survival rate was 29.5%. Conditional survival analysis revealed that, among patients who survived to 2 years post-diagnosis, the probability of surviving one additional year (to year 3) was 83%. Similarly, patients surviving to 3 years had an 82% likelihood of surviving to year 4. Several factors were significantly associated with increased mortality in multivariate analysis, including CLTI with ulceration, the need for hemodialysis, intensive care unit admission at diagnosis, ischemic heart disease, nursing facility residency, and a history of stroke. Reduced mortality was associated with clopidogrel use and an outpatient diagnosis. Aspirin use was linked to reduced mortality in univariate but not multivariate analysis. Within 1 year of diagnosis, both major amputation and endovascular revascularization were significant for mortality in univariate analysis. Subsequent multivariate analysis showed that major amputation within 1 year was significant for mortality at years 0, 1, and 3. CONCLUSIONS: Conditional survival improves in patients with CLTI who survive beyond the first year post-diagnosis, yet 5-year mortality remains high. This finding highlights the substantial early mortality risk in patients with CLTI but also indicates that surviving the first year significantly improves subsequent survival odds. Several factors contribute to early mortality risk in CLTI, many of which are modifiable, underscoring the importance of targeted interventions in this high-risk population.

来源:J Vasc Surg,查看原文。版权归原作者所有。

引用

  1. AbouAyash J, Abdu RW, Kania TA, et al. Conditional survival analysis and risk factors for mortality in patients with chronic limb-threatening ischemia. J Vasc Surg. 2025. PMID: 40348292. doi:10.1016/j.jvs.2025.05.004

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。